Evidence map›Paper›PMID 42676188›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Self-Feeding Living Materials Enabled by Cell Responsive Glycogen Nanoparticles as Metabolic Batteries.

Melvin Gurian, Niels G A Willemen, Isa R Porsul, Nicole Bassous, Jarno Hiemstra, Yu Na, Debby Gawlitta, Su Ryon Shin, Jeroen Leijten

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melvin Gurian *Faculty of Science and Technology, Department of BioEngineering Technologies, Leijten Laboratory, TechMed Centre, University of Twente, Enschede, the Netherlands.ORCID https://orcid.org/0000-0001-5522-3875
Niels G A Willemen *Faculty of Science and Technology, Department of BioEngineering Technologies, Leijten Laboratory, TechMed Centre, University of Twente, Enschede, the Netherlands.ORCID https://orcid.org/0000-0003-1061-3313
Isa R PorsulFaculty of Science and Technology, Department of BioEngineering Technologies, Leijten Laboratory, TechMed Centre, University of Twente, Enschede, the Netherlands.ORCID https://orcid.org/0009-0002-7968-7636
Nicole BassousDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jarno HiemstraFaculty of Science and Technology, Department of BioEngineering Technologies, Leijten Laboratory, TechMed Centre, University of Twente, Enschede, the Netherlands.ORCID https://orcid.org/0009-0008-1213-3368
Yu NaFaculty of Science and Technology, Department of BioEngineering Technologies, Leijten Laboratory, TechMed Centre, University of Twente, Enschede, the Netherlands.
Debby GawlittaDepartment of Oral and Maxillofacial Surgery, Prosthodontics and Special Dental Care, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0001-9622-3062
Su Ryon ShinDivision of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-0864-6482
Jeroen LeijtenFaculty of Science and Technology, Department of BioEngineering Technologies, Leijten Laboratory, TechMed Centre, University of Twente, Enschede, the Netherlands.ORCID https://orcid.org/0000-0002-8063-207X

Funding

European Research Council 101266635Health Holland 2022TKI2334ZonMw
6 · The paper itself

Abstract

Scaling engineered living materials to clinically relevant dimensions is limited by diffusion-dependent depletion of oxygen and nutrients, which rapidly induces metabolic failure. We introduce glycogen as a nutritional nanoparticle that provides cell-mediated, autonomous nutrient release to support long-term survival under extreme metabolic stress. We demonstrate that human mesenchymal stromal cells (hMSCs) survive for weeks in anoxia and serum deprivation when provided extracellular glycogen. Contrary to long-held assumptions, hMSCs secrete glycogen-degrading enzymes, enabling cell-density-controlled extracellular glycogenolysis and sustained release of glucose and metabolic intermediates, positioning glycogen as the first-of-its-kind metabolic battery. This cell-responsive process maintains metabolic activity, limits glycolytic acidosis, and enhances pro-angiogenic signaling. To translate this mechanism into a versatile materials platform, we engineered core-shell dextran-tyramine microcapsules that stably encapsulate glycogen while permitting diffusion of enzymes and degradation products. Integrated into centimeter-scale GelMA constructs, these microcapsules maintained hMSC viability and function for at least 1 month under anoxia. In vivo, glycogen-loaded implants promote deep cellular infiltration, enhanced matrix remodeling, increased M2 macrophage polarization, and orchestrated accelerated vascularization. This work establishes the novel concept of glycogen-based nutritional nanoparticles as metabolic batteries to endow engineered tissues with autonomous self-feeding capacity, enabling scalable and functional living materials for regenerative medicine and related technologies.

Indexed as

Biocompatible MaterialsGlycogenMesenchymal Stem CellsNanoparticlesAnimalsCell SurvivalGlucoseHumansBiocompatible MaterialsGlucoseGlycogenglucoseMSCpolysaccharidestissue engineeringvascularization

Identifiers

PMID42676188
PMCPMC13579083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.